We show that DRD2 mRNA and protein can be detected in all breast cancer cell lines tested, suggesting DRD2 expression alone cannot be used to predict whether the self-renewal of a cell line will be sensitive to thioridazine. The gene discussed is DRD2; the disease is breast cancer.